Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Research Project (R01)
Project #
5R01AT000486-05
Application #
6830686
Study Section
Special Emphasis Panel (ZRG1-SSS-9 (22))
Program Officer
Pontzer, Carol H
Project Start
2000-07-01
Project End
2006-10-31
Budget Start
2004-11-01
Budget End
2006-10-31
Support Year
5
Fiscal Year
2005
Total Cost
$299,309
Indirect Cost

  Institution

Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305

  Publications

Gardner, Christopher D; Oelrich, Beibei; Liu, Jenny P et al. (2009) Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation. Prostate 69:719-26
Swami, Srilatha; Krishnan, Aruna V; Moreno, Jacqueline et al. (2009) Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. Int J Cancer 124:2050-9
Swami, Srilatha; Krishnan, Aruna V; Moreno, Jacqueline et al. (2007) Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer. J Nutr 137:205S-210S
Swami, Srilatha; Krishnan, Aruna V; Peehl, Donna M et al. (2005) Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity. Mol Cell Endocrinol 241:49-61
Swami, Srilatha; Raghavachari, Nalini; Muller, Uwe R et al. (2003) Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 80:49-62
Gardner, Christopher D; Messina, Mark; Lawson, Larry D et al. (2003) Soy, garlic, and ginkgo biloba: their potential role in cardiovascular disease prevention and treatment. Curr Atheroscler Rep 5:468-75